NEW YORK (Reuters Health) – Chemotherapy given before surgery in patients with small-cell urothelial cancer (SCUC) downstages tumors and results in significantly improved survival, a team from the…
NEW YORK (Reuters Health) – Metformin appears to lower the risk of developing liver cancer in patients with type 2 diabetes, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant…
NEW YORK (Reuters Health) – After a standard course of combination chemotherapy for advanced non-small-cell lung cancer, maintenance therapy with a single agent improves overall survival and progression-free…
NEW YORK (Reuters Health) – The decline in cognitive function in children with Prader-Willi syndrome can be stabilized with ongoing growth-hormone (GH) therapy, a Dutch team reports in…
NEW YORK (Reuters Health) – Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the…
NEW YORK (Reuters Health) – Blood pressure lowering provides protection against intracranial bleeding in patients with cerebrovascular disease, including those on antithrombotic therapy, according to results of a…
NEW YORK (Reuters Health) – Nutritional support, mainly in the form of oral nutritional supplements, boosts protein and energy intake, body weight and grip strength in malnourished patients…
Influenza infection is a common reason children and teens are hospitalized in the United States each year. While the flu vaccine is safe and effective just over half…
Recent studies show that sales and deaths related to opiate pain relievers have quadrupled over the last decade in the United States. Also, illicit drug use among pregnant…
Nearly everyone agrees, health care costs in the United States are becoming unsustainable. These higher costs not only affect Medicare and Medicaid services but private sector health insurance…
NEW YORK (Reuters Health) – Patients with advanced non-small-cell lung cancer have higher response rates to a regimen that includes an albumin-bound formulation of paclitaxel (nab-paclitaxel) than solvent-based…
